Cognito looks to light, sound for potential Alzheimer’s treatment
Digital health startup Cognito shared results of a Phase 2 trial of its device, intended to treat Alzheimer’s disease using gamma frequency light and sound. Based on the results, it plans to launch a pivotal study of the treatment.